GSK PLC's ticker is and the CUSIP is 37733W204. A total of 4 filers reported holding GSK PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,326,871 | -41.4% | 36,603 | -42.4% | 0.13% | +26.5% |
| Q2 2023 | $2,263,576 | +107.1% | 63,512 | +106.8% | 0.10% | +1.0% |
| Q1 2023 | $1,092,771 | -53.0% | 30,713 | -53.6% | 0.10% | -4.7% |
| Q4 2022 | $2,326,058 | +967.0% | 66,194 | +792.5% | 0.11% | +404.8% |
| Q3 2022 | $218,000 | -87.4% | 7,417 | -81.4% | 0.02% | -87.6% |
| Q2 2022 | $1,733,000 | -3.3% | 39,805 | -3.3% | 0.17% | +1.2% |
| Q1 2022 | $1,793,000 | -11.9% | 41,170 | -10.8% | 0.17% | -9.2% |
| Q4 2021 | $2,036,000 | – | 46,147 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,444,460 | $451,112 | 41.96% |
| Eversept Partners, LP | 3,259,342 | $118,151,148 | 10.00% |
| Sio Capital Management, LLC | 509,000 | $18,451,250 | 5.71% |
| Callodine Capital Management, LP | 475,000 | $17,218,750 | 4.80% |
| EQUITY INVESTMENT CORP | 3,277,362 | $118,804,373 | 3.70% |
| Clean Yield Group | 207,739 | $7,802,677 | 3.46% |
| Robinson Value Management, Ltd. | 128,116 | $4,644,205 | 3.46% |
| Camber Capital Management LP | 2,850,000 | $103,313 | 3.40% |
| Hillman Capital Management, Inc. | 232,864 | $8,441,320 | 3.25% |
| Soleus Capital Management, L.P. | 943,000 | $34,183,750 | 3.15% |